Earlybird Venture Capital

💥 EUR 50B in funding potential, 100k attendees, and 1000+ exhibitors: 4YFN has established itself as one of the top annual startup gatherings in the European ecosystem. This year, Marvel Fusion CFO Dr. Nicolas Burkardt will take the stage with Earlybird Principal Nina Mayer, HV Capital Partner Fabian Gruner, alongside T.Capital Vice President Karine Peters who will moderate a session on the Marvel Fusion funding journey. They’ll illuminate the real strategic value of a co-investment, what’s beyond the capital, and the challenges that arise on that journey. Marvel Fusion continues to pioneer advancements in fusion energy and celebrated a successful Series B of EUR 70M just a few months ago. Let’s see how they've leveraged the new capital and take a closer look at their growth.   🎤 For ‘VC + CVC: Partnering for Impact – The Marvel Fusion Investment Story’ head to Beta Lab, Hall 8.1 - 4YFN, on March 5th from 10:20-11 am to catch the session! See a link in the comments section to learn more about it. Cc: Dr. Hendrik Brandis, Dr. Moritz Belling, Moritz von der Linden, Heike Freund, Jay Anna Harris-Theis, Elisheva Marcus, Rylee Mora #Spain #Barcelona #Startups #VC #Future #4YFN25

From a hospital bed with meningitis to landing a job at Greywolf Therapeutics, Valeriya S.'s (Val) journey is a powerful reminder that determination can lead to unexpected opportunities. 💪 Val’s experience working at Grey Wolf, particularly through a challenging fundraising process, shaped her current role as an investor at Earlybird Health. She’s seen firsthand how crucial it is to have investors who understand the science and the vision behind a company. Having come full circle – as an operator at Grey Wolf to now investor at Earlybird Health which backs Grey Wolf – Val is dedicated to supporting bold, innovative ideas in biotech that can transform patient outcomes. It’s not only about the capital – it’s about supporting founders through challenges to create lasting change. See link in the comments section below to read more about her journey. 🌍 cc: Rabab Nasrallah, PhD #HealthcareInnovation #PatientOutcomes #InvestingInTheFuture

🧡 As our population ages, healthier aging has never been more urgent. 🌍 At the Global Healthspan Summit 2025 in Riyadh, Saudi Arabia, Earlybird Health investors Thom Rasche, Rabab Nasrallah, PhD, and Dr. Christoph Massner joined scientific leaders to drive actionable progress in aging research, innovation, and global collaboration. ✍️ The event showcased groundbreaking advancements in healthspan science and underscored the importance of cross-sector collaboration to create real-world impact. Throughout the Summit, the focus extended beyond longevity to enhancing quality of life, raising global awareness of the need for healthier aging. ⭐ At Earlybird Health, we remain committed to accelerating innovation in healthcare, improving people’s lives, and ensuring healthier lifespans for everyone. cc: Hevolution Foundation, Freskida Goni #GlobalHealthspanSummit2025 #Healthspan #GHS2025 #EarlybirdHealth For more information, check out the link in the comments. 

🌀“The Catalyst Program will marry the macro and the micro. You’ve got a successful, long-standing VC with that bird’s eye view at the table with operators who can translate that advice specifically for the industry and position of the operator,” says Folley Ogundele, CRO of finmid who has recently joined our Catalyst program. The Catalyst program was designed by Earlybird to fulfill our promise of meeting founders at eye level, providing world-class sparring partners, and offering insights from those who’ve walked in their shoes. Today, we’re introducing Folley to kick off our interview series where the catalysts share first-hand insights for founders and operators. With leadership experience at top FinTech companies like Stripe, Wise, and now finmid, Folley reveals the make-or-break factors he’s tracked over the years. Dive into his "Hierarchy of Focus"—a must-read framework on startup priorities—via the link in the comments. This is a five-minute read from an industry expert. Stay tuned for more strategic advice in the coming weeks. 💫 Cc: Tim Rehder, Akash Bajwa, Samantha Wessels, Luke Miller, Elisheva Marcus, Rylee Mora

⚡ A revitalized brand, a hackathon, market expansion, positive clinical trial results, an acquisition, and a couple of soonicorns… What more can we ask for in the first month of 2025? In case you missed something, we’ve got a packed newsletter for you featuring Earlybird portfolio companies including Isar Aerospace, HiveMQ, Hive, Greenlyte Carbon Technologies, finmid, Matchory and Earlybird Health’s Oculis. Not to mention, Earlybird spotlights on Dr. Hendrik Brandis, Paul Klemm, Tim Rehder, Dr. Andre Retterath, Dr. Moritz Belling, Laurin Class, and Earlybird Health’s Dr. Christoph Massner. 🔥 And that’s just January. Buckle up—there’s a lot more coming. #VC #Founders #Startups

 🎬 Vision Lab Cohort 6 is officially live! As part of our pan-European approach, we believe great founders come from everywhere. Vision Lab is an Earlybird program focused on supporting entrepreneurs from migration backgrounds. Vision Lab’s Startup Cohort 6 channels expertise from Ukraine, Brazil, India, and more: because diversity is always an asset. From scalable tailored prosthetics to cutting-edge carbon capture solutions, these startups tackle critical challenges with fresh perspectives. At the recent kick-off event, Vision Lab program supporter Vlad Kovtun and Jonathan Doliva from Bain & Company engaged with founders on how to reach success by addressing the flip side of the coin: Why do so many startups fail? This event was further supported by Earlybird Vision Lab Partner Benjamin Wilkening and Program Managers Judith Gantschnigg and Charles Hamilton II, made possible by Vision Lab Partners such as Bain & Company, Egon Zehnder, Handelsblatt Media Group, and many more. Thank you to Techspace for hosting us in Berlin. It was a fabulous venue! Meet the cohort: DatafabriQ, HealthCaters, Horus Prosthetics, papayo, beams, Muuv, Meloon GmbH, Zapdeck, TMA, The Hazardous Goods Companion, mixNmatch, Claro AI, Workademy Cc: Dr. Hendrik Brandis, Elisheva Marcus, Rylee Mora, and Techspace’s Philip Ellis & Mona Otten #VisionLab #Entrepreneurs #Diversity #Founders #VC

🔐 AI is transforming VC—no secret, no surprise. But where does cybersecurity fit into this shift? Earlybird Principal Dr. Moritz Belling will take the stage at Zero One Hundred Conferences to address this topic, moderating a panel on the "Usage of AI & Digitalization of the VC industry. Cybersecurity: Trend or Main Challenge?" Speakers joining this panel include Future Energy Ventures Partner Jan Palasinski, Paladin Capital Group Managing Director Kenneth Pentimonti, and Headline Partner Dominic Wilhelm. Secure a spot for this unique conversation with industry leaders, set against the backdrop of the renowned 0100 DACH Conference in Vienna, which brings together leaders from an established network of key players in innovation. Link in the comments section below. Cc: Alena Hloba, Dr. Andre Retterath, Elisheva Marcus, Rylee Mora #0100DACH #Network #VentureCapital #AI #CyberSecurity

💫 “This was a project the entire company had been waiting for. We had been living with the frustration of knowing that an outdated brand didn’t represent who we were on the inside. We have a diverse team that is invested in supporting the cutting-edge every day and we wanted that energy reflected in our new brand,” says Sara Fee Kirschhausen, Earlybird Principal and Brand Project Lead. For a look behind the curtain, a deeper understanding of our evolution as a firm, and tips on conquering a rebrand of your own, head to our blog & read our latest post: ‘Behind the Brand.’ This article features quotes from Earlybird Partner Dr. Andre Retterath, Earlybird Principal Sara Fee Kirschhausen, and Earlybird Health Principal Dr. Christoph Massner. 🔗 Link in the comments section below. Cc: Dr. Hendrik Brandis, Dr. Christian Nagel, Paul Klemm, Tim Rehder, Elisheva Marcus, Rylee Mora  #VC #EuropeanVC #Brand #Startup #Founders #Legacy 

🚀 Today we’re unveiling a new brand that reflects our energetic culture and beliefs. As a diverse team invested in supporting the cutting-edge every day, it’s about time to sharpen our appearance. We’ve been backing European innovators since 1997 and we continue to invest in the future—for one simple reason: we believe. As sparring partners for Europe’s most visionary founders, Earlybird & Earlybird Health are laser-focused on respective specialties, backing game-changing tech companies and transforming healthcare. As we transition into this new chapter, Earlybirds Dr. Andre Retterath, Paul Klemm, and Tim Rehder are becoming General Partners. For the last 7 years, they’ve collaborated with the Earlybird team and Co-Founders, Dr. Hendrik Brandis and Dr. Christian Nagel, to empower the Earlybird legacy for the decades ahead. Meanwhile, Earlybird Health is shaping the future of healthcare and achieving better patient outcomes through a tech-agnostic approach to investing, positively impacting 500 million patients. Earlybird Health is led by Partners Thom Rasche, John Yianni, Lionel Carnot, Florent Gros, and Alexander Müller. What’s more, we're launching our Catalyst Program, with top operators turned Venture Partners, ready to help scale your vision. Our first cohort will hone in on go-to-market strategies for Fintech and Software founders. Our current initiatives have only become more robust. Supporting founders through:  -Our EagleEye AI Platform (Because data + gut feelings = 🦄) -Vision Lab opening doors for entrepreneurs with migration backgrounds -Enhanced startup success & portfolio resources With an international team and a multi-generational partnership, we have a lot of different perspectives, but there is one thing we most certainly agree on: we’re all in from day one. Check out the link to our new website in the comments section below. #VentureCapital #Innovation #EuropeanTech #Healthcare #Startups

🚀 Let’s keep FemTech Founders in focus as we kick off 2025 with the first Digital Health Cocktail Hour of the year! Explore the FemTech landscape with founders and experts who share their journeys, discuss challenges, and highlight the transformative role of data strategies in advancing women’s healthcare. Speakers include Felicia von Reden, Co-founder of Ovom Care, and Zara Liew, Director of Clinical Partnerships at Lindus Health & more – moderated by Guy Spigelman, EMEA Lead Healthcare and Life Sciences Startups at AWS. This event includes networking opportunities with founders, VCs & innovators, plus 1:1 Office Minutes sessions with representatives from Earlybird Health, Amazon Web Services (AWS), Future4Care, Charité - Universitätsmedizin Berlin's Berlin Institute of Health, and Merantix AI Campus. Not to mention, great music and cocktails. 📅 February 5, 6-8 pm CET 📍 Merantix AI Campus, Max-Urich-Straße 3, 13355 Berlin   🙌 Thanks to all our co-hosts and speakers. Let’s connect, innovate, and celebrate FemTech. Please visit the link in the comments to register. 🔗 #DHCHBerlin #EarlybirdHealth #FemTech #DigitalHealth #Berlin cc: Thom Rasche, Rabab Nasrallah, PhD, Dr. Christoph Massner, Freskida Goni